AI Diagnostics Clinical

The First AI Cleared to Check Your Child's Teeth

Dr Ali Vatan Ali Vatan
·

VideaHealth just received the broadest FDA clearance in dental AI history, including the first AI approved for paediatric patients. What does this mean for families and clinicians?

The First AI Cleared to Check Your Child's Teeth

In January 2024, VideaHealth received FDA 510(k) clearance for what is now the broadest dental AI platform ever approved: more than 30 AI algorithms covering virtually every common dental disease, including the first-ever AI cleared for paediatric patients as young as three (VideaHealth, 2024). That last part is the bit I want to focus on.

Why paediatric diagnosis is so difficult

Diagnosing caries in children is hard, and I don’t mean hard in a “requires concentration” way, I mean the imaging itself fights you. Mixed dentition, that phase where baby teeth and adult teeth coexist, creates radiographic images that are trickier to read. Overlapping teeth, developing roots, and the sheer variability of a growing mouth make subtle lesions easy to miss, not because dentists are careless but because the imaging is inherently challenging.

VideaHealth’s data claims an 80% improvement in true paediatric caries identification compared to clinicians working without AI assistance (VideaHealth, 2024), which is a significant number. A narrative review in PMC examining FDA-approved AI solutions in dental imaging confirmed high accuracy, sensitivity, and specificity across these platforms, particularly for caries detection, though it noted that several newer platforms still lack independent clinical validation (PMC, 2025). That caveat matters.

What this means for clinicians

I’ll say it plainly: AI-assisted diagnostics is extremely beneficial for clinicians. A second pair of eyes that doesn’t get tired at 4pm on a Friday, and doesn’t carry the cognitive biases we all have, is a real advantage.

But it is a diagnostic aid, not a replacement for examination. It highlights areas of concern on a radiograph; it doesn’t examine the child, take a history, or notice that a four-year-old is guarding the left side of their mouth. Those observations still require a human in the room. The best way to use it, I think, is to do your examination, read the radiographs, then let the AI give its analysis. Where there’s disagreement, look again. Where there’s agreement, you have added confidence. That’s how good diagnostic tools should work.

What this means for families

For parents, the experience of going to the dentist doesn’t change. Your child still sits in the same chair, still has the same interaction with their dentist, and the AI runs in the background, invisible to the patient. But it should give families reassurance, because patients think, “I’m getting cutting-edge service, but it’s my dentist providing this,” and they’d be right. The technology enhances what the clinician can do; it doesn’t replace them.

I keep coming back to the same point: the patient-clinician relationship is built on trust, and you cannot build trust with AI the same way you do with a human. A parent needs to look their child’s dentist in the eye and feel confident this person cares about their kid. No algorithm provides that.

The broader picture

VideaHealth’s clearance is part of a larger trend. A review of the FDA-approved landscape found thirteen companies offering twenty-nine cleared AI products for dental imaging, covering caries detection, cephalometric analysis, and periodontal disease assessment (PMC, 2025). An entire sector is maturing rapidly. VideaHealth has raised approximately $70 million in total funding, and its platform now covers bitewing, periapical, and panoramic radiographs for patients aged three and above (BusinessWire, 2024), making it one of the most versatile diagnostic AI tools available to dentists.

Where I stand

I’m optimistic about this technology, with caveats. The 80% improvement figure is impressive, but I want to see independent, peer-reviewed validation over large patient populations, across different radiographic equipment, different demographics, and different clinical settings. Company-reported data is a starting point, not an endpoint.

What I don’t want is for this to become a marketing tool that undermines clinical skill. AI can help us find the cavities, but it can’t help us earn a family’s trust, and that part is still on us.

References